IP Verse

Chimeric Antigen Receptors (Cars) Targeting Hematologic Malignancies, Compositions And Methods Of Use Thereof

Patent No. EP3261651 (titled "Chimeric Antigen Receptors (Cars) Targeting Hematologic Malignancies, Compositions And Methods Of Use Thereof") was filed by Chen on Feb 26, 2016. The application was issued on May 4, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
JAMES POOLEFeb 3, 2023CARPMAELS & RANSFORD
MARGARET DIXONFeb 3, 2023MEWBURN ELLIS
PATENT BOUTIQUEFeb 3, 2023PATENT BOUTIQUE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3261651

CHEN
Application Number
EP16756524A
Filing Date
Feb 26, 2016
Status
Revoked
Feb 21, 2025
Publication Date
May 4, 2022
External Links
Slate, Register , Google Patents